US Bancorp’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-839
Closed 3765
2018
Q2
$0 Hold
839
﹤0.01% 3765
2018
Q1
$0 Hold
839
﹤0.01% 3769
2017
Q4
$0 Hold
839
﹤0.01% 3742
2017
Q3
$0 Hold
839
﹤0.01% 3702
2017
Q2
$0 Hold
839
﹤0.01% 3678
2017
Q1
$1K Hold
839
﹤0.01% 3517
2016
Q4
$1K Hold
839
﹤0.01% 3504
2016
Q3
$1K Hold
839
﹤0.01% 3496
2016
Q2
$0 Hold
839
﹤0.01% 3711
2016
Q1
$1K Hold
839
﹤0.01% 3497
2015
Q4
$1K Hold
839
﹤0.01% 3563
2015
Q3
$1K Hold
839
﹤0.01% 3548
2015
Q2
$1K Hold
839
﹤0.01% 3527
2015
Q1
$2K Hold
839
﹤0.01% 3466
2014
Q4
$1K Buy
+839
New +$909 ﹤0.01% 3491

US Bancorp's BTX.WS Position: Q3 2018 in Review

US Bancorp sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 839 shares.

US Bancorp first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $2K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • US Bancorp reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • US Bancorp sold 839 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • US Bancorp first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • US Bancorp's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $2K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on US Bancorp's 13F filing for Q3 2018, filed 1 Nov 2018.